Tang-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
202
Total Value
1807581363
Accession Number
0001214659-25-007882
Form Type
13F-HR
Manager Name
Tang-Capital-Management
Data Enrichment
98% identified
198 identified4 unidentified

Holdings

202 positions
Manager:
Search and click to pin securities to the top
Page 5 of 11
Janux Therapeutics, Inc.
Shares:150.0K
Value:$4.0M
CYTOKINETICS INC
Shares:100.0K
Value:$4.0M
COMPASS Pathways plc
Shares:1.4M
Value:$4.0M
TG THERAPEUTICS, INC.
Shares:100.0K
Value:$3.9M
GENMAB A/S
Shares:200.0K
Value:$3.9M
NOVAVAX INC
Shares:600.0K
Value:$3.8M
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Shares:40.0K
Value:$3.7M
Vera Therapeutics, Inc.
Shares:150.0K
Value:$3.6M
SOLENO THERAPEUTICS INC
Shares:50.0K
Value:$3.6M
Ventyx Biosciences, Inc.
Shares:3.1M
Value:$3.6M
Nuvalent, Inc.
Shares:50.0K
Value:$3.5M
Revolution Medicines, Inc.
Shares:100.0K
Value:$3.5M
Kezar Life Sciences, Inc.
Shares:720.0K
Value:$3.5M
Biohaven Ltd.
Shares:140.0K
Value:$3.4M
Stoke Therapeutics, Inc.
Shares:500.0K
Value:$3.3M
SpringWorks Therapeutics, Inc.
Shares:74.3K
Value:$3.3M
Vir Biotechnology, Inc.
Shares:500.0K
Value:$3.2M
Third Harmonic Bio, Inc.
Shares:929.7K
Value:$3.2M
PRECISION BIOSCIENCES INC
Shares:673.3K
Value:$3.2M
Black Diamond Therapeutics, Inc.
Shares:2.1M
Value:$3.2M